Reasons to Invest

We are creating integrated treatment programs that combine safe and effective drug compounds with technology-enabled psychotherapy programs. Virtual reality of the senses, artificial intelligence, biometrics, and data mining will work together in tandem with psychedelics and talk therapy to personalize each patient’s experience.

Our research programs target areas of high unmet need and significant market opportunity. We are focused on creating long-term shareholder value by creating a diverse portfolio of intellectual property and regulatory protection.

We are working hard to make a meaningful difference in the lives of many, while providing above average returns to our stakeholders.